GlycoMimetics
GLYC
$1.64
Share price
-4.09%
Change (1 day)
19.71%
Change (1 year)
Categories
GlycoMimetics (GLYC) - Net assets
Net assets on the balance sheet as of September 2023 : $46.54 M
According to GlycoMimetics
's latest financial reports the company has $46.54 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
GlycoMimetics - Net assets on balance sheet (from 2012 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $42.92 M | -47.39% |
| 2021-12-31 | $81.6 M | -36.36% |
| 2020-12-31 | $0.12 B | -16.85% |
| 2019-12-31 | $0.15 B | -24.95% |
| 2018-12-31 | $0.20 B | 71.65% |
| 2017-12-31 | $0.11 B | 239.09% |
| 2016-12-31 | $35.3 M | -12.78% |
| 2015-12-31 | $40.47 M | -20.34% |
| 2014-12-31 | $50.8 M | 1647.37% |
| 2013-12-31 | $2.9 M | -76.79% |
| 2012-12-31 | $12.52 M | 48.14% |
| 2011-12-31 | $8.45 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | 147,649.51% | 🇺🇸 USA |
 Pfizer PFE | $89.28 B | 191,720.43% | 🇺🇸 USA |
 Sanofi SNY | $82.20 B | 176,500.35% | 🇫🇷 France |
 Palatin Technologies PTN | -$11.39 M | -124.46% | 🇺🇸 USA |
 bluebird bio
BLUE | $0.22 B | 378.08% | 🇺🇸 USA |